Siddha medicine Bala karappan kudineer(internal) and Karappan thailam(external) for Bala karappan (Atopic dermatitis) in childre
Phase 2
- Conditions
- Health Condition 1: L209- Atopic dermatitis, unspecified
- Registration Number
- CTRI/2021/07/034772
- Lead Sponsor
- Government Siddha Medical College
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Itching Erythema Papules Vesicles Oozing Crusting Scaling Lichenification
Exclusion Criteria
Psoriasis Scabies Photo dermatitis Ichthyosis vulgaris Pityriasis alba
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Reduction in EASI Score <br/ ><br>Reduction in Clinical symptoms <br/ ><br>Photo evidence before and after treatmentTimepoint: Reduction in EASI Score <br/ ><br>Reduction in Clinical symptoms <br/ ><br>Photo evidence before and after treatment
- Secondary Outcome Measures
Name Time Method Comparing Safety parameters before and after treatmentTimepoint: 21 days
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What are the active compounds in Bala karappan kudineer and Karappan thailam that target inflammatory pathways in atopic dermatitis in children?
How does the efficacy of Siddha Bala karappan kudineer and Karappan thailam compare to corticosteroids and immunosuppressants in pediatric atopic dermatitis?
Which biomarkers, such as filaggrin mutations or Th2 cytokine levels, predict response to Siddha Bala karappan therapies in children with atopic dermatitis?
What is the safety profile and adverse event management strategy for Siddha Bala karappan kudineer and Karappan thailam in pediatric atopic dermatitis trials?
Are there combination approaches or alternative Siddha formulations that enhance the therapeutic effects of Bala karappan kudineer and Karappan thailam in atopic dermatitis management?